INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC 13F/NEWVerified data

RENAISSANCE TECHNOLOGIES LLC bought MDT

13F filer · Medtronic plc · MEDTRONIC PLC

Side
BUY
Δ value
$247.81M
Shares
3.17M
Price
$78.23
Executed
Not disclosed
Disclosed
Aug 13, 2026

MDT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
42/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    NEW

  • Relative size+12 / 25

    $247.8M quarter-over-quarter change

  • Filing timing0 / 15

    Not applicable — 13F reports quarter-end holdings, execution dates are not disclosed

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

Other disclosed activity · MDT

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
MM
Marinaro MichaelPresident
MDTMedtronic plc
Grant or award
A

Evidence

Verified data

Read directly from the primary public document; every field below is as reported by the filer.

Source

Document
SEC Form 13F-HR
Publisher
U.S. Securities and Exchange Commission (EDGAR)
Document ID
0001037389-26-000059

Timestamps

Event (reported)
Not reported
Published
Aug 13, 2026
Ingested by INSIDER
Nov 4, 22:39 UTC
Last re-read
Nov 5, 07:36 UTC

Extracted facts

Filer
RENAISSANCE TECHNOLOGIES LLC
Role
13F filer
Transaction
NEW
Asset
MEDTRONIC PLC
Ticker
MDT
Shares
3.17M
Price per share
$78.23
Value
$247,812,378
Owned after transaction
3.17M shares

What this establishes

RENAISSANCE TECHNOLOGIES LLC reported this position change in a quarterly 13F holdings report. 13F shows quarter-end positions only — it does not say when during the quarter shares were bought or sold.

Extraction

Method
13F information table XML
Confidence
1.00
13F filer
RENAISSANCE TECHNOLOGIES LLCcik:0001037389
Issuer
Medtronic plccik:0001613103

Revision history · 0

No field has changed since this record was first ingested.

Company events

  • Officer or director change8-KOct 19, 2026
  • Other material event8-KSep 17, 2026
  • Quarterly report (10-Q)
  • Market events+10 / 10

    Results of operations (earnings) filed 19 days after the trade (8-K)

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    —
    43.0K sh
    Nov 2, 2026
    Nov 4, 2026
    traded Nov 2, 2026
    +2d
    SEC FORM 4

    Evidence

    5
    MM
    Marinaro MichaelPresident
    MDTMedtronic plc
    Grant or award
    A—
    16.4K sh
    Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    +2dSEC FORM 4

    Evidence

    9
    MM
    Marinaro MichaelPresident
    MDTMedtronic plc
    Grant or award
    A—
    6,547 sh
    Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    +2dSEC FORM 4

    Evidence

    18
    LE
    Lofton Kevin EDirector
    MDTMedtronic plc
    Other acquisition or disposition
    J—
    182 sh
    Oct 15, 2026Oct 21, 2026
    traded Oct 15, 2026
    +6dSEC FORM 4

    Evidence

    28
    MM
    Marinaro MichaelEVP, Pres MedSurg and Americas
    MDTMedtronic plc
    Open-market sale · 10b5-1 plan
    SELL$1.00M
    10.4K sh
    Oct 15, 2026Oct 16, 2026
    traded Oct 15, 2026
    +1dSEC FORM 4

    Evidence

    12
    BL
    Blomquist Denise L.Chief Accounting Officer
    MDTMedtronic plc
    Gift
    G—
    600 sh
    Sep 15, 2026Sep 16, 2026
    traded Sep 15, 2026
    +1dSEC FORM 4

    Evidence

    30
    Kevin HernRJoint
    MDTMedtronic plc
    Sale
    SELL$15K – $50KAug 24, 2026Sep 1, 2026
    traded Aug 24, 2026
    +8dHOUSE PTR

    Evidence

    12
    MM
    Marinaro MichaelEVP, Pres MedSurg and Americas
    MDTMedtronic plc
    Tax withholding
    F$100K
    1,084 sh
    Aug 20, 2026Aug 24, 2026
    traded Aug 20, 2026
    +4dSEC FORM 4

    Evidence

    25
    RM
    Richard Dean McCormickSelf
    MDTMedtronic plc
    Sale
    SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
    traded Jul 30, 2026
    +15dHOUSE PTR

    Evidence

    35
    Julie JohnsonDJoint
    MDTMedtronic plc
    Partial sale
    SELL$1,001 – $15KMay 7, 2025Aug 5, 2026
    traded May 7, 2025
    +455dHOUSE PTR

    Evidence

    16
    WR
    Walter Matthew R.SVP, Chief HR Officer
    MDTMedtronic plc
    Tax withholding
    F$237K
    2,840 sh
    Jun 4, 2026Jun 8, 2026
    traded Jun 4, 2026
    +4dSEC FORM 4

    Evidence

    9
    BL
    Blomquist Denise L.Chief Accounting Officer
    MDTMedtronic plc
    Tax withholding
    F$20K
    237 sh
    Jun 5, 2026Jun 8, 2026
    traded Jun 5, 2026
    +3dSEC FORM 4

    Evidence

    30
    Gilbert Ray Cisneros, Jr.DSelf
    MDTMedtronic plc
    Partial sale
    SELL$1,001 – $15KMay 15, 2026Jun 8, 2026
    traded May 15, 2026
    +24dHOUSE PTR

    Evidence

    19
    MM
    Marinaro MichaelEVP, Pres MedSurg and Americas
    MDTMedtronic plc
    Tax withholding
    F$622K
    7,471 sh
    Jun 4, 2026Jun 8, 2026
    traded Jun 4, 2026
    +4dSEC FORM 4

    Evidence

    9
    WR
    Walter Matthew R.SVP, Chief HR Officer
    MDTMedtronic plc
    Option exercise
    M—
    8,449 sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    17
    MM
    Marinaro MichaelEVP, Pres MedSurg and Americas
    MDTMedtronic plc
    Option exercise
    M—
    19.0K sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    9
    MM
    Marinaro MichaelEVP, Pres MedSurg and Americas
    MDTMedtronic plc
    Option exercise
    M—
    17.1K sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    9
    BL
    Blomquist Denise L.Chief Accounting Officer
    MDTMedtronic plc
    Option exercise
    M—
    1,621 sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    13
    BL
    Blomquist Denise L.Chief Accounting Officer
    MDTMedtronic plc
    Option exercise
    M—
    1,712 sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    17
    WR
    Walter Matthew R.SVP, Chief HR Officer
    MDTMedtronic plc
    Option exercise
    M—
    9,149 sh
    May 26, 2026May 28, 2026
    traded May 26, 2026
    +2dSEC FORM 4

    Evidence

    10-Q
    Sep 3, 2026
  • Results of operations (earnings)8-KSep 1, 2026
  • Annual report (10-K)10-KJun 18, 2026
  • Results of operations (earnings)8-KJun 3, 2026
  • Officer or director change8-KMay 18, 2026
  • Quarterly report (10-Q)10-QFeb 24, 2026
  • Results of operations (earnings)8-KFeb 17, 2026
  • Quarterly report (10-Q)10-QNov 25, 2025
  • Results of operations (earnings)8-KNov 18, 2025
  • Officer or director change8-KNov 3, 2025